Nadine Tung - Division of Medical Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 388 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis

Kelly Metcalfe,Tomasz Huzarski,Jacek Gronwald,Joanne Kotsopoulos,Raymond Kim,Pal Moller,Tuya Pal,Amber Aeilts,Andrea Eisen,Beth Karlan,Louise Bordeleau,Nadine Tung,

British Journal of Cancerno. 2 (2024): 269-274

Cited0Views0WOSNATUREBibtex

Uptake of risk-reduction, surveillance, and therapeutic interventions among patients with breast cancer with pathogenic germline variants

Allison W. Kurian, Sarah M. Nielsen Young, Emily M. Russell,Flavia Facio, Chad Moretz,Brandie Heald, Rachel Ellsworth, Daniel Pineda-Alvarez, Ed Esplin, W. Michael Korn,Nadine M. Tung

Journal of Clinical Oncologyno. 16_suppl (2024): 10579-10579

Cited0Views0Bibtex

Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations

Joanne Kotsopoulos,Jacek Gronwald,Tomasz Huzarski,Pål Møller,Tuya Pal,Jeanna M McCuaig,Christian F Singer,Beth Y Karlan,Amber Aeilts,Charis Eng,Andrea Eisen,Louise Bordeleau,

JAMA oncologyno. 4 (2024): 484-492

Cited0Views0WOSBibtex

HOPE: Harnessing olaparib, palbociclib, and endocrine therapy for BRCA1/2-associated HR+, HER2- metastatic breast cancer

Payal Deepak Shah, Alexandra Torres, Megan Aaron,Vivek Narayan,Hayley Michelle Knollman,Angela R. Bradbury,Angela DeMichele,Mark E. Robson,Nadine M. Tung,Susan M. Domchek

Journal of Clinical Oncologyno. 16_suppl (2024): 10616-10616

Cited0Views0Bibtex

Abstract PO3-18-11: A011801 (CompassHER2 RD): Postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer

Ciara O'Sullivan,Karla Ballman, Linda McCall, Tyler Zemla,Anna Weiss, Melissa Mitchell, Victoria Blinder,Nadine Tung,William Irvin,Myounghee Lee, Sailaja Kamaraju,Matthew Goetz,

Cancer Researchno. 9_Supplement (2024): PO3-18

Cited0Views0Bibtex

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations

Jan Lubinski,Joanne Kotsopoulos,Pal Moller,Tuya Pal,Andrea Eisen, Larissa Peck,Beth Y Karlan,Amber Aeilts,Charis Eng,Louise Bordeleau,William D Foulkes,Nadine Tung,

JAMA oncology（2024）

Cited0Views0WOSBibtex

The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations

Steven A. Narod,Kelly Metcalfe,Amy Finch,An-Wen Chan,Susan Randall Armel,Amber Aeilts,Andrea Eisen,Beth Karlan,Louise Bordeleau,Nadine Tung,William D. Foulkes,Susan L. Neuhausen,

Hereditary Cancer in Clinical Practiceno. 1 (2024): 1-7

Cited0Views0WOSBibtex

Abstract PD18-01: Adjuvant Trastuzumab Emtansine Versus Paclitaxel plus Trastuzumab for Stage I HER2+ Breast Cancer: 5-year results and correlative analyses from ATEMPT (TBCRC033)

Paolo Tarantino,Nabihah Tayob,Chau T Dang,Denise Yardley,Steven J. Isakoff,Vicente Valero,Meredith Faggen,Therese Mulvey,Ron Bose,Douglas Weckstein,Antonio C. Wolff,Katherine Reeder-Hayes,

Cancer Researchno. 5_Supplement (2023): PD18-01

Cited1Views0Bibtex

Independent validation of the HER2DX genomic test in HER2-positive breast cancer treated with neoadjuvant paclitaxel, trastuzumab and pertuzumab (THP): a correlative analysis from the DAPHNe phase II clinical trial

Adrienne Waks,Esther R. Ogayo,Laia Pare,Mercedes Marin-Aguilera,Fara Braso-Maristany,Patricia Galvan,Oleguer Castillo,Olga Martinez-Saez,Ana Vivancos,Patricia Villagrasa,Paolo Tarantino,Neelam Desai,

CANCER RESEARCHno. 5 (2023)

Cited0Views0Bibtex

Abstract OT2-18-02: OlympiaN: a phase 2, multicenter, open-label study to assess the efficacy and safety of neoadjuvant olaparib monotherapy and olaparib plus durvalumab in patients with BRCA mutations and early-stage HER2-negative breast cancer

Judith Balmaña, Mike Dymond, Elizabeth S. Lowe,Natalia Lukashchuk,Maria Winter,Nadine Tung

Cancer Researchno. 5_Supplement (2023): OT2-18

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn